• Technology and Data
  • Front End Sales and Marketing
  • Allergy
  • HIV
  • Women's Health
  • Migraine
  • Compounding
  • Continuous Glucose Monitoring
  • Mental Health Awareness
  • Veterinary Pharmacy
  • CBD
  • Infectious Disease
  • Eye Health
  • Digestive Health
  • Biosimilars
  • Influenza
  • Shingles
  • COPD Management
  • Pediatrics
  • Generics
  • Pain Management
  • COVID-19
  • Immunization
  • Oncology
  • Anticoagulants
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Respiratory
  • Heart Health
  • Cardiovascular Clinical Consult

FDA's new Rx label rule may limit lawsuits


The Food & Drug Administration has announced a new format for prescription drug labeling that will organize the most important information needed by healthcare providers in a more accessible and easy-to-read fashion, according to the agency. But what may have started as an effort to decrease the 300,000 preventable adverse drug events that occur each year, has led some groups to accuse the FDA of attempting to protect manufacturers from consumer liability suits.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.